The researchers then tested a drug FDA - approved for treatment of multiple sclerosis, which acts by preventing certain immune cells from leaving lymph nodes for sites of inflammation. (sciencedaily.com)
«Nose to Brain Delivery of BIIB033 via the Olfactory Region for the Regenerative treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device» (lens.unifi.it)
This will be achieved with the development of a biomaterial - based innovative formulation that will be applied with the aid of an endoscope and a medical device assembly as a matrix patch to the nasal olfactory region for the chronic treatment of Multiple Sclerosis (MS). (lens.unifi.it)